Meet the future of

Myopia Control

Comprehensive evidence-based myopia treatment analytics. Intuitive decision support metrics delivered via our pioneering, patent-pending, monitoring tools

Based on Research, Driven by Innovation

Myopia management made easy

Inspiring confidence in clinical decision making for myopia control

The patient-friendly communication tool you've been waiting for!

Explaining myopia management can seem a daunting prospect. But it doesn't have to be. Our mEYEguide product turns what can be a long complicated conversation into a short effective one. We provide a personalised analysis for every patient. Best of all, parents leave with all the information on their mobile phone.

Raising the bar in myopia management

"Ocumetra delivers personalised myopia care solutions and vital decision support to practitioners in a rapidly changing field of clinical practice. Our pioneering technology makes advanced myopia treatment accessible to all."
Ian Flitcroft & James Loughman

Co-Founders of Ocumetra

Problems We Solve

Personalised adaptive care for every myopia patient

Clinical Dilemmas

Intuitive centile charts derived from our extensive normative database provide the evidence to guide your practice...
    Early detection of pre-myopia
    Biometry-free AL estimation
    Accurate classification of myopia risk

Treatment efficacy concerns

Managing continued progression during myopia treatment is an important clinical challenge. Refractogram provides unique:

    Treatment efficacy analysis
    Myopia progression projections
    Treatment continuity guidance

Keeping patients engaged

With patient-focussed outputs, our centile charts simplify the treatment conversation at every stage of the myopia care pathway.

    Identifies at-risk patients
    Illustrates treatment efficacy
    Facilitates treatment optimisation

Clinical Trial Solutions

Clinical trials don't always provide data applicable to clinical practice. Ocumetra provides a solution:

    Extensive normative reference database
    Real world trial interpretation
    Realistic treatment expectation

Join our mailing list and we will let you know all the news!